awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26823757-34D5EB05-43EC-4A4D-B471-DF2C9E51EC55
Q26823757-34D5EB05-43EC-4A4D-B471-DF2C9E51EC55
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26823757-34D5EB05-43EC-4A4D-B471-DF2C9E51EC55
Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)
P2860
Q26823757-34D5EB05-43EC-4A4D-B471-DF2C9E51EC55
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26823757-34D5EB05-43EC-4A4D-B471-DF2C9E51EC55
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2a78bd876e53b8a4c14feb5054b3e2bf67a5c9f3
P2860
Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.